Strengths

TOMZ’s negative TTM ROIC indicates capital is not earning adequate returns, leaving it structurally weaker than profitable medtech peers with positive reinvestment economics.

The company’s long cash conversion cycle ties up working capital for extended periods, reducing liquidity efficiency versus peers that convert inventory and receivables faster.

Limited margin data disclosure itself suggests a smaller, less mature operating base than diversified peers, which typically support steadier scale-driven profitability.

Weaknesses

A debt-to-equity ratio above 2.0 signals a leveraged balance sheet, making TOMZ more financially constrained than peers with lower funding risk and flexibility.

The quick ratio below 1.0 indicates near-term liquidity pressure, leaving TOMZ less resilient than peers that can cover short-term obligations from liquid assets.

Negative net debt to EBITDA reflects weak or negative earnings capacity, which is structurally inferior to peers with positive leverage capacity and refinancing optionality.

The very long cash conversion cycle increases cash needs and working-capital drag, putting TOMZ behind peers that recycle capital more efficiently into growth.

Opportunities

If TOMZ improves working-capital discipline, the large cash conversion gap offers more upside than peers already operating near efficient cycle levels.

Any sustained margin normalization would have outsized impact because the current low-return base leaves TOMZ more sensitive to incremental operating leverage than stronger peers.

Balance-sheet repair could improve strategic flexibility, and that optionality is more valuable for TOMZ than for peers already funded with stronger liquidity.

Threats

Persistent negative returns on invested capital threaten TOMZ’s ability to compound value, while stronger peers can reinvest internally at higher rates.

High leverage and weaker liquidity increase refinancing and dilution risk, leaving TOMZ more exposed than peers with stronger balance-sheet buffers.

Extended cash conversion cycles can amplify demand shocks and supplier pressure, making TOMZ operationally more fragile than peers with faster cash generation.

Overall Score

TOMZ is structurally weaker than peers because negative capital returns, elevated leverage, and poor working-capital efficiency constrain profitability, flexibility, and resilience.